Maternova is a leading brand in the realm of maternal and neonatal health. They are actively involved in the International Maternal Newborn Health Conference (IMNHC) 2023, which serves as a vital platform for advancing solutions and accelerating progress in this field. Recently held in Cape Town, South Africa, after a hiatus of over eight years, the conference brought together more than 1,700 stakeholders from around the world.

Maternova plays a crucial role in improving maternal and newborn survival rates and preventing stillbirths. They are committed to achieving the ambitious targets outlined in the Sustainable Development Goals (SDGs). During the conference, Maternova's CEO, Dr.

Gabriela Salvador, along with other representatives, worked to bridge the gap between stakeholders, facilitate dialogue, and drive scalable innovations. At Maternova, they offer a wide range of solutions for maternal and newborn health, including rapid tests, nutrition expertise, and ongoing research and development. Their dedicated team, which includes a board of scientific advisors, is committed to making a positive impact in the field of neonatal health and survival.

With a mission to provide effective and innovative solutions, Maternova is at the forefront of driving progress and improving the lives of mothers and newborns worldwide